SAVE THE DATES
Luncheon with the Experts on Facebook LIVE
October 22, Pat & Chuck Murphy. It was 2004 and Pat and Chuck were preparing to move to a new home – life was good, personally and professionally. Then Pat suddenly developed what the doctor thought was bronchitis. When she went into heart failure they discovered a neuroendocrine tumor on her bronchus. Chuck became the researcher, the person Pat could turn to for answers, for emotional support, for loving care; he is her advocate.
October 29, Alexandria Phan, MD, FACP, hematologist-medical oncologist at UT Health, MD Anderson Cancer Center in Texas, specializes in treating patients with cancers of the gastrointestinal system, cancer of unknown primary, neuroendocrine tumors of any primary site, thyroid and parathyroid cancers. “I believe that every patient’s cancer treatment should be personalized, and that cancer care should be based on scientific evidence and best practices,” says Dr. Phan. “I remind myself daily that what I do is a privilege.”
November 5, Simron Singh, MD, MPH, FRCPC, is a medical oncologist and affiliate scientist in the Odette Cancer Research Program at Sunnybrook Research Institute in Toronto, Canada. He is co-head of a multidisciplinary neuroendocrine clinic at Sunnybrook’s Odette Cancer Center, one of the first in the region. He is involved in numerous activities in the care of neuroendocrine cancer patients including the role of Ki-67 as a prognostic marker, and the utilization of health care resources in the diagnosis and treatment of neuroendocrine tumor patients.